Area of land subject to lease.

No definition available.

Name:	nxtc_AreaOfLandLeased
Namespace Prefix:	nxtc_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

- Definition

Area of lease terminated.

+ References

No definition available.

+ Details

Name:	nxtc_AreaOfLeaseTerminated
Namespace Prefix:	nxtc_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

- Definition

Represents the collaboration agreements cost sharing percentage.

+ References

No definition available.

+ Details

Name:	nxtc_CollaborationAgreementsCostSharingPercentage
Namespace Prefix:	nxtc_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Expense recognized specifically associated with lease termination charges or penalties.

+ References

No definition available.

+ Details

Name:	nxtc_LeaseTerminationExpense
Namespace Prefix:	nxtc_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of consideration in sale of assets.

+ References

No definition available.

+ Details

Name:	nxtc_SaleOfAssetCashConsideration
Namespace Prefix:	nxtc_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Purchase price of expected business acquisition prior to consideration being transferred. Excludes asset acquisition.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-7

+ Details

Name:	us-gaap_BusinessCombinationPriceOfAcquisitionExpected
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

+ Details

Name:	us-gaap_GainLossOnDispositionOfAssets1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Subparagraph (b)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-18

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 420
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.P.4.b.1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 420
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482047/420-10-45-3

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 420
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.P.3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479823/420-10-S99-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476148/220-40-50-21

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476148/220-40-50-6

+ Details

Name:	us-gaap_RestructuringCharges
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481674/830-30-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 855
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483399/855-10-50-2

+ Details

Name:	us-gaap_SubsequentEventLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=nxtc_ResearchAndDevelopmentCollaborativeAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=nxtc_LegochemBiosciencesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=nxtc_AvereTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Subsequent Events (Details)			1 Months Ended	3 Months Ended
Subsequent Events (Details)	Aug. 01, 2026 USD ($)	Jul. 14, 2026 USD ($)	Jul. 28, 2026 USD ($)	Sep. 30, 2026 USD ($)	Aug. 06, 2026	Jul. 27, 2026 USD ($)	Jul. 01, 2026	Jun. 30, 2026	Dec. 31, 2025	Nov. 30, 2022
Research Collaboration and Co-Development Agreement
Subsequent Events
Collaboration agreements cost sharing percentage (as a percent)								50.00%	50.00%	50.00%
Subsequent Event
Subsequent Events
Restructuring cost				$ 2,400,000
Area of lease terminated			39,432
Area of land leased			29,864			69,296
Lease termination fee			$ 800,000
Sale of asset, cash consideration	$ 500,000
Gain (loss) on disposal of assets	$ 0
Subsequent Event \| Research Collaboration and Co-Development Agreement \| LigaChem Biosciences
Subsequent Events
Collaboration agreements cost sharing percentage (as a percent)					100.00%		50.00%
Subsequent Event \| Avere Therapeutics, Inc.
Subsequent Events
Aggregate purchase price		$ 320,000,000